Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Neuroinflammation in Hypertension.Minocycline for Resistant Hypertension: a Randomized Double Blind Placebo-Controlled Trial

NCT04478500 is registered in ClinicalTrials.gov with Royal Perth Hospital as lead sponsor.

NCT NCT04478500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04478500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Neuroinflammation in Hypertension.Minocycline for Resistant Hypertension: a Randomized Double Blind Placebo-Controlled Trial
Lead sponsor
Royal Perth Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
July 2, 2020
Completion date
February 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resistant hypertension